title: Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation.
authors.affiliation: FHI 360. Electronic address: jstanback@fhi360.org.
authors.forename: John
authors.initials: J
authors.lastname: Stanback
authors.affiliation: FHI 360.
authors.forename: Elena
authors.initials: E
authors.lastname: Lebetkin
authors.affiliation: FHI 360.
authors.forename: Tracy
authors.initials: T
authors.lastname: Orr
authors.affiliation: US Agency for International Development.
authors.forename: Shawn
authors.initials: S
authors.lastname: Malarcher
mesh_terms: D003157:Community Pharmacy Services; D003226:Congresses as Topic; D003245:Consensus Statements as Topic; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D003906:Developing Countries; D004343:Drug Implants; D019317:Evidence-Based Medicine; D016656:Family Planning Policy; D005193:Family Planning Services / Q000193:education / Q000592:standards; D005260:Female; D006292:Health Priorities; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D014481:United States; D054702:United States Agency for International Development; D014837:Voluntary Health Agencies
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; D017258:Medroxyprogesterone Acetate